share_log

InnovAge Holding Corp. (NASDAQ:INNV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

InnovAge Holding Corp. (NASDAQ:INNV) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Innovage Holding Corp.(納斯達克股票代碼:INNV)第三季度業績剛剛公佈:以下是分析師對明年的預測
Simply Wall St ·  05/09 19:57

Investors in InnovAge Holding Corp. (NASDAQ:INNV) had a good week, as its shares rose 4.4% to close at US$4.26 following the release of its quarterly results. Revenue of US$193m came in 2.5% ahead of expectations, although statutory earnings didn't fare nearly so well, recording a loss of US$0.04, a 14% miss. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

Innovage Holding Corp.(納斯達克股票代碼:INNV)的投資者度過了愉快的一週,在公佈季度業績後,其股價上漲了4.4%,收於4.26美元。1.93億美元的收入比預期高出2.5%,儘管法定收益表現不佳,虧損0.04美元,跌幅14%。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

earnings-and-revenue-growth
NasdaqGS:INNV Earnings and Revenue Growth May 9th 2024
納斯達克GS:INNV 收益和收入增長 2024 年 5 月 9 日

Following the latest results, InnovAge Holding's four analysts are now forecasting revenues of US$848.7m in 2025. This would be a meaningful 14% improvement in revenue compared to the last 12 months. InnovAge Holding is also expected to turn profitable, with statutory earnings of US$0.029 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$847.0m and earnings per share (EPS) of US$0.031 in 2025. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

根據最新業績,Innovage Holding的四位分析師現在預測2025年的收入爲8.487億美元。與過去12個月相比,這將使收入大幅增長14%。預計InnovAge Holding也將實現盈利,法定每股收益爲0.029美元。然而,在最新業績公佈之前,分析師曾預計2025年收入爲8.470億美元,每股收益(EPS)爲0.031美元。因此,在最近的業績公佈之後,整體情緒似乎略有下降——收入估計沒有重大變化,但分析師確實對每股收益的預測進行了小幅下調。

It might be a surprise to learn that the consensus price target was broadly unchanged at US$6.50, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic InnovAge Holding analyst has a price target of US$7.00 per share, while the most pessimistic values it at US$6.00. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

得知共識目標股價基本保持不變,爲6.50美元,這可能會令人驚訝,分析師明確表示,預期的收益下降預計不會對估值產生太大影響。共識目標股價只是個別分析師目標的平均值,因此——可以很方便地看到基礎估計值的範圍有多廣。最樂觀的Innovage Holding分析師將目標股價定爲每股7.00美元,而最悲觀的分析師則將其目標股價定爲6.00美元。由於估值範圍如此狹窄,分析師顯然對他們認爲的業務價值有相似的看法。

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting InnovAge Holding's growth to accelerate, with the forecast 11% annualised growth to the end of 2025 ranking favourably alongside historical growth of 7.2% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.7% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect InnovAge Holding to grow faster than the wider industry.

現在從大局來看,我們理解這些預測的方法之一是了解它們與過去的業績和行業增長估計相比如何。分析師肯定預計,InnovAge Holding的增長將加速,預計到2025年底的年化增長率爲11%,而過去五年的歷史年增長率爲7.2%。相比之下,我們的數據表明,預計類似行業的其他公司(有分析師報道)的收入將以每年6.7%的速度增長。顯而易見,儘管增長前景比最近更加光明,但分析師也預計,InnovAge Holding的增長速度將超過整個行業。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for InnovAge Holding. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

最大的擔憂是,分析師下調了每股收益預期,這表明InnovAge Holding可能會面臨業務不利因素。令人高興的是,收入預測沒有重大變化,預計該業務的增長速度仍將快於整個行業。共識目標股價沒有實際變化,這表明根據最新估計,該業務的內在價值沒有發生任何重大變化。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for InnovAge Holding going out to 2026, and you can see them free on our platform here.

根據這種思路,我們認爲該業務的長期前景比明年的收益重要得多。我們對Innovage Holding的預測將持續到2026年,你可以在我們的平台上免費查看。

You can also see our analysis of InnovAge Holding's Board and CEO remuneration and experience, and whether company insiders have been buying stock.

您還可以看到我們對InnovAge Holding董事會和首席執行官薪酬和經驗的分析,以及公司內部人士是否一直在購買股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論